Literature DB >> 17059928

Clinical feasibility of free-breathing, gadolinium-enhanced magnetic resonance angiography for assessing extracardiac thoracic vascular abnormalities in young children with congenital heart diseases.

Sheung-Fat Ko1, Chi-Di Liang, Chung-Cheng Huang, Shu-Hang Ng, Ming-Jang Hsieh, Jen-Pin Chang, Min-Chi Chen.   

Abstract

OBJECTIVE: Congenital heart diseases in pediatric patients are associated with a wide variety of extracardiac thoracic vascular abnormalities. This study analyzed the value of gadolinium-enhanced magnetic resonance angiography during quiet free breathing for assessing extracardiac thoracic vascular abnormalities in young children with congenital heart diseases.
METHODS: Fifty-three children with congenital heart diseases (age range, 1 day-40 months; mean, 10.9 months) associated with extracardiac thoracic vascular abnormalities who had undergone both free-breathing, gadolinium-enhanced magnetic resonance angiography and cardiac catheterization, surgical intervention, or both within 2 weeks were reviewed. Diagnostic findings on gadolinium-enhanced magnetic resonance angiography among patients grouped according to 3 major conditions of conotruncal abnormalities (n = 33), aortic or venous abnormalities (n = 11), and pulmonary vascular abnormalities (n = 9), as well as associated extracardiac thoracic vascular abnormality findings, were compared with findings made by using cardiac catheterization, surgical intervention, or both.
RESULTS: Extracardiac thoracic vascular abnormality findings on gadolinium-enhanced magnetic resonance angiography were similar to those on catheterization, surgical intervention, or both in patients with conotruncal abnormalities (124 vs 127, P = .083), aortic or venous abnormalities (36 vs 33, P = .083), and pulmonary vascular abnormalities (24 vs 25, P = .317). The overall sensitivity of gadolinium-enhanced magnetic resonance angiography for detection of these lesions identified by means of catheterization, surgical intervention, or both was 97.9%. However, gadolinium-enhanced magnetic resonance angiography revealed 11 additional extracardiac thoracic vascular abnormalities that were not found on cardiac catheterization. The kappa coefficient for the correlation of image quality and diagnostic value of gadolinium-enhanced magnetic resonance angiography by using a 4-point-scale (1 = nondiagnostic to 4 = excellent) assessed by 2 independent reviewers was excellent (mean score = 3.66), with superb interobserver agreement (kappa = 0.727-0.874).
CONCLUSIONS: Free-breathing, gadolinium-enhanced magnetic resonance angiography is clinically feasible for detailed anatomic delineation and treatment planning of various extracardiac thoracic vascular abnormalities in young children with congenital heart diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17059928     DOI: 10.1016/j.jtcvs.2006.05.007

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

Review 1.  Neonatal cardiac imaging.

Authors:  Rajesh Krishnamurthy
Journal:  Pediatr Radiol       Date:  2010-04

2.  Partial anomalous pulmonary venous drainage in young pediatric patients: the role of magnetic resonance imaging.

Authors:  Eugénie Marie-Christine Riesenkampff; Boris Schmitt; Bernhard Schnackenburg; Michael Huebler; Vladimir Alexi-Meskishvili; Roland Hetzer; Felix Berger; Titus Kuehne
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

3.  Efficacy and safety of deep sedation by non-anesthesiologists for cardiac MRI in children.

Authors:  Rini Jain; Toni Petrillo-Albarano; W James Parks; Jeffrey F Linzer; Jana A Stockwell
Journal:  Pediatr Radiol       Date:  2012-11-25

4.  ASCI 2010 appropriateness criteria for cardiac magnetic resonance imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group.

Authors:  Kakuya Kitagawa; Byoung Wook Choi; Carmen Chan; Masahiro Jinzaki; I-Chen Tsai; Hwan Seok Yong; Wei Yu
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-24       Impact factor: 2.357

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.